Recent Financing
Recent Raise
NewLimit is a San Francisco-based developer of cell reprogramming and epigenetic longevity medicines using an AI-driven genomics platform.
Focus Areas
Recent Investors
Valuation as of 06/02/2026
Total Raised
Funding rounds
Investors
